Table 2

Difficult to treat cancer-related symptoms identified by physicians
Symptoms All physicians (n = 311) Palliative care teams (n = 226) PCUs (n = 79) p-value Specialists (n = 128) Non-specialists (n = 183) p-value
frequency % frequency % frequency % frequency % frequency %
Numbness/Hypesthesia 240 77.2 180 79.6 55 69.6 0.165 99 77.3 141 77.0 1.000
Languor/Fatigue 225 72.3 161 71.2 61 77.2 0.276 99 77.3 126 68.9 0.122
Delirium 170 54.7 119 52.7 48 60.8 0.447 73 57.0 97 53.0 0.490
Taste alteration 166 53.4 124 54.9 42 53.2 0.029 77 60.2 89 48.6 0.050
Edema (Local edema/Anasarca) 150 48.2 109 48.2 39 49.4 0.821 59 46.1 91 49.7 0.565
Pain 146 46.9 113 50.0 31 39.2 0.226 55 43.0 91 49.7 0.250
Anorexia/Weight loss 140 45.0 109 48.2 30 38.0 0.108 64 50.0 76 41.5 0.165
Abdominal discomfort 131 42.1 98 43.4 31 39.2 0.735 55 43.0 76 41.5 0.816
Stomatitis/Xerostomia 122 39.2 89 39.4 33 41.8 0.141 54 42.2 68 37.2 0.409
Depression 116 37.3 86 38.1 30 38.0 0.175 41 32.0 75 41.0 0.122
Adjustment disorder 113 36.3 73 32.3 39 49.4 0.014 47 36.7 66 36.1 1.000
Dyspnea/Breathlessness 113 36.3 77 34.1 35 44.3 0.162 48 37.5 65 35.5 0.811
Nausea/Vomiting (other) 101 32.5 75 33.2 24 30.4 0.893 38 29.7 63 34.4 0.392
Dysphagia/Deglutition disorder 100 32.2 68 30.1 31 39.2 0.281 50 39.1 50 27.3 0.036
Sleep disorder/Insomnia 93 29.9 69 30.5 23 29.1 0.796 42 32.8 51 27.9 0.379
Constipation (caused by opioid use) 84 27.0 69 30.5 15 19.0 0.038 34 26.6 50 27.3 0.898
Nausea/Vomiting (during chemotherapy) 76 24.4 71 31.4 5 6.3 0.000 27 21.1 49 26.8 0.284
Muscle weakness 65 20.9 46 20.4 19 24.1 0.346 34 26.6 31 16.9 0.047
Nausea/Vomiting (caused by opioid use) 61 19.6 51 22.6 10 12.7 0.690 24 18.8 37 20.2 0.774
Constipation (not caused by opioid use) 59 19.0 47 20.8 11 13.9 0.377 28 21.9 31 16.9 0.305
Muscle cramp 42 13.5 31 13.7 11 13.9 0.741 23 18.0 19 10.4 0.064
Diarrhea 40 12.9 34 15.0 6 7.6 0.136 16 12.5 24 13.1 1.000
Anemia 29 9.3 24 10.6 5 6.3 0.344 16 12.5 13 7.1 0.177
Others 11 3.5 6 2.7 5 6.3 0.325 4 3.1 7 3.8 0.770

Multiple answers allowed, p-value based on Chi-square test.

Iwase et al.

Iwase et al. BMC Complementary and Alternative Medicine 2012 12:222   doi:10.1186/1472-6882-12-222

Open Data